Drug Profile
Flavivirus vaccine - Distributed Bio
Alternative Names: Centivax flavi; Centivax flavi vaccineLatest Information Update: 28 Jan 2022
Price :
$50
*
At a glance
- Originator Distributed Bio
- Class Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Flavivirus infections
Most Recent Events
- 28 Jan 2022 No recent reports of development identified for research development in Flavivirus-infections(Prevention) in USA (Parenteral)
- 21 Dec 2017 Distributed Bio has patent protection for Centivax technology (Distributed Bio website, December 2017)
- 21 Dec 2017 Early research in Flavivirus infections (Prevention) in USA (Parenteral) before December 2017 (Distributed Bio pipeline, December 2017)